References
- Adlercreutz H, van der WJ, Kinzel J, et al. (1995). Lignan and isoflavonoid conjugates in human urine. J Steroid Biochem Mol Biol 52:97–103
- Adolphe JL, Whiting SJ, Juurlink BH, et al. (2010). Health effects with consumption of the flax lignan secoisolariciresinol diglucoside. Br J Nutr 103:929–38
- Aspinall SL, Zhao X, Good CB, et al. (2011). Intervention to decrease glyburide use in elderly patients with renal insufficiency. Am J Geriatr Pharmacother 9:58–68
- Bloedon LT, Balikai S, Chittams J, et al. (2008). Flaxseed and cardiovascular risk factors: Results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 27:65–74
- Buck K, Zaineddin AK, Vrieling A, et al. (2010). Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 92:141–53
- Carreau C, Flouriot G, Bennetau-Pelissero C, Potier M. (2008). Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells. J Steroid Biochem Mol Biol 110:176–85
- Cornish SM, Chilibeck PD, Paus-Jennsen L, et al. (2009). A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab 34:89–98
- Dean B, Chang S, Doss GA, et al. (2004). Glucuronidation, oxidative metabolism, and bioactivation of enterolactone in Rhesus monkeys. Arch Biochem Biophys 429:244–51
- Demark-Wahnefried W, Polascik TJ, George SL, et al. (2008). Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev 17:3577–87
- Franklin SS, Gustin W, Wong ND, et al. (1997). Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96:308–15
- Fravel MA, McDanel DL, Ross MB, et al. (2011). Special considerations for treatment of type 2 diabetes mellitus in the elderly. Am J Health Syst Pharm 68:500–9
- Hallund J, Tetens I, Bugel S, et al. (2008). The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovasc Dis 18:497–502
- Hu C, Yuan YV, Kitts DD. (2007). Antioxidant activities of the flaxseed lignan secoisolariciresinol diglucoside, its aglycone secoisolariciresinol and the mammalian lignans enterodiol and enterolactone in vitro. Food Chem Toxicol 45:2219–27
- Jenab M, Thompson LU. (1996). The influence of flaxseed and lignans on colon carcinogenesis and beta-glucuronidase activity. Carcinogenesis 17:1343–8
- Juurlink BH. (2001). Therapeutic potential of dietary phase 2 enzyme inducers in ameliorating diseases that have an underlying inflammatory component. Can J Physiol Pharmacol 79:266–82
- Kitts DD, Yuan YV, Wijewickreme AN, Thompson LU. (1999). Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 202:91–100
- Lucas EA, Wild RD, Hammond LJ, et al. (2002). Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87:1527–32
- Mangoni AA, Jackson SH. (2004). Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br J Clin Pharmacol 57:6–14
- Pan A, Sun J, Chen Y, et al. (2007). Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: A randomized, double-blind, cross-over trial. PLoS One 2:e1148, 1–7
- Penttinen P, Jaehrling J, Damdimopoulos AE, et al. (2007). Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148:4875–86
- Penttinen-Damdimopoulou PE, Power KA, Hurmerinta TT, et al. (2009). Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice. Mol Nutr Food Res 53:996–1006
- Prasad K. (2000). Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 9:220–5
- Skoff RA, Waterbury NV, Shaw RF, et al. (2011). Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide. J Manag Care Pharm 17:664–71
- Wang W, Liu LQ, Higuchi CM, Chen H. (1998). Induction of NADPH: quinone reductase by dietary phytoestrogens in colonic Colo205 cells. Biochem Pharmacol 56:189–95
- Westcott, ND, Muir, AD, Lafond G, et al. (2002). Factors affecting the concentration of a nutraceutical lignan in flax seed. In: Bruulsema TW, ed. Proceedings of the Symposium on Fertilizing Crops for Functional Food, November 11, 2002, Indianapolis, Indiana, USA. Norcross, GA: Potash & Phosphate Institute/Potash & Phosphate Institute of Canada (PPI/PPIC), Chapter 4. Symposium sponsored by American Society of Agonomy, Soil Science Society of America, Crop Science Society of America, and PPI/PPIC
- Whiting SJ. (2010). Oxidative stress and nutritional supplementation intervention study (oxi-Stress). Available from: http://clinicaltrials.gov/ct2/show/NCT01234506 [last accessed 16 Nov 2012]
- Zhang W, Wang X, Liu Y, et al. (2008). Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. Br J Nutr 99:1301–9